Nuo Therapeutics, Inc. (AURX) › Operating IncomeNuo Therapeutics, Inc. (AURX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$5.40M2011: -$3.51M2012: -$12.89M2013: -$18.10M2014: -$23.39M2015: -$41.32M2017: -$15.53M2018: -$1.50M2019: -$969.2K2020: -$378.1K2021: -$90.7K2022: -$3.32M2023: -$3.17M2024: -$2.46M2025: -$2.52M-$2.52M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$2.52M-2.4%2024-$2.46M+22.4%2023-$3.17M+4.6%2022-$3.32M-3562.3%2021-$90.7K+76.0%2020-$378.1K+61.0%2019-$969.2K+35.6%2018-$1.50M+90.3%2017-$15.53M—2015-$41.32M-76.6%2014-$23.39M-29.3%2013-$18.10M-40.3%2012-$12.89M-266.9%2011-$3.51M+35.0%2010-$5.40M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share